Bioventus (BVS) Other Non Operating Income (2020 - 2026)
Bioventus (BVS) posted Other Non Operating Income of $427000.0 for Q1 2026, up 230.98% on a QoQ basis from -$326000.0 in Q3 2025.
Bioventus (BVS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Bioventus' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $427000.0 for Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to $427000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$460000.0 (down 189.31% YoY) and the FY2025 annual result came in at -$326000.0, changed N/A from the prior year.
- Other Non Operating Income was $427000.0 for Q1 2026 at Bioventus, up from -$326000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.6 million in Q2 2023 and bottomed at -$9.4 million in Q4 2022.
- A 5-year average of -$804000.0 and a median of -$326000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 440.96% — and 2023, when it soared 337.47%.
- Bioventus' Other Non Operating Income stood at -$9.4 million in 2022, then jumped by 93.83% to -$581000.0 in 2023, then jumped by 72.63% to -$159000.0 in 2024, then tumbled by 105.03% to -$326000.0 in 2025, then jumped by 230.98% to $427000.0 in 2026.
- Business Quant data shows BVS's Other Non Operating Income at $427000.0 in Q1 2026, -$326000.0 in Q3 2025, and -$561000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Bioventus | 828.42 Mn | 792.57 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 427,000.00 |
| Sep 27, 2025 | -326,000.00 |
| Jun 28, 2025 | -561,000.00 |
| Jun 29, 2024 | -159,000.00 |
| Mar 30, 2024 | -63,000.00 |
| Dec 31, 2023 | -581,000.00 |
| Sep 30, 2023 | -494,000.00 |
| Jul 1, 2023 | -513,000.00 |
| Apr 1, 2023 | 1.59 Mn |
| Dec 31, 2022 | -9.41 Mn |
| Oct 1, 2022 | -115,000.00 |
| Jul 2, 2022 | -604,000.00 |
| Apr 2, 2022 | 363,000.00 |
| Dec 31, 2021 | 2.76 Mn |
| Oct 2, 2021 | -757,000.00 |
| Jul 3, 2021 | -1.65 Mn |
| Apr 3, 2021 | -419,000.00 |
| Dec 31, 2020 | -4.49 Mn |
| Sep 26, 2020 | 3.29 Mn |
| Jun 27, 2020 | 1.34 Mn |